SupremeCourt

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Sunday, August 25, 2013

Colgate v Pepsodent: Comparative Advertising

Posted on 7:10 AM by Unknown
Image from here
Recently, in a case of comparative advertising, the Delhi High Court denied granting an interim injunction against Hindustan Unilever Ltd (HUL) (here). Colgate Palmolive (India) Ltd. brought an action against HUL for its ads relating to its product ‘Pepsodent GermiCheck Superior Power’ as these ads allegedly disparaged Colgate’s toothpaste ‘Colgate Dental Cream Strong Teeth’. 


We have blogged about comparative advertising here, here, here, here and here.

Colgate made the following submissions: 

First, it was contended that the claim made by HUL that Pepsodent GermiCheck had ‘130% attack power’ was blatantly false. This false statement violated several provisions of the Advertising Councils Code as well as The Drugs and Cosmetics Act, as it amounted to ‘misbranding’. 

Second, the print and TV commercial portrayed Colgate’s product in bad light and falsely depicted that the use of Colgate could cause cavities. The advertisements were analyzed frame by frame and the following observations were made: 

The TV commercial depicts that Triclosan an ingredient in Pepsodent stays in the mouth four hours after brushing and qualifies a ‘preventive cavity test’. But Colgate contended that no such test exists in the world. Also, while the Pepsodent Boy passed this test, the Colgate Boy was shown to have failed. In another frame, the Colgate Boy was shown brushing his teeth in an improper manner, whose teeth had gaps (indicating cavities) and whose mother seemed very unhappy. All this implied, as per the plaintiff, that Colgate’s toothpaste could cause cavities and was therefore disparaging of their product. 

The Print Ad: It was argued that the words ‘Pepsodent now better than Colgate Strong Teeth’ were meant to convey that Colgate Strong Teeth was no longer a good product. Also, the word ‘Attaaaack’ used in the ad was an attack on Colgate and not on the cavity causing germs. 

Thirdly, HUL’s past record showed that it had a history of making false claims in respect of its products. Cases such as: Hindustan Unilever Ltd v Colgate Pamolive Ltd, 1998 SC 526 and Reckitt Benckiser (India) Ltd. v. Hindustan Unilever Ltd. 200 (2013) DLT 563 (Dettol v. Lifebuoy case) were cited. 

Colgate apprehended a loss of market share if the HUL was not restrained from circulating these ads. 

HUL responded: 

HUL asked the court not to adopt a hyper technical view and not to analyse an advertisement like a statute or a clause of an agreement. Taken as a whole, neither the TV commercial nor the print advertisement denigrates the product or the brand of Colgate. 

On the claim that Pepsodent GSP was a better product, it was argued that there was no denigration of Colgate Strong Teeth. In this regard, the decision in Dabur Colortek was cited to show that courts have allowed comparative advertising and have allowed manufacturers to claim superiority over their competitor’s products, so long as there is no denigration of the other product. The results of the in vivo and in vitro tests supported the statements of HUL (that Pepsodent GSP actually had a 130% germ attack power) were also relied on. 

Court 

The court first examined the law concerning comparative advertisements. The first principles developed in Dabur Colortek were “for a Plaintiff to succeed in an action based on malicious falsehood, the necessary ingredients are that (i) a false statement was made which is calculated to cause financial damage (ii) that it was made maliciously with an intention to cause injury and (iii) the impugned statement has resulted in a special damage. The law in England was referred to as laying down that: (i) a trader is entitled to say that his goods were the best; in doing so he could compare his goods with another (ii) say that his goods are better than that of the rival trader in this or that respect (iii) whether the statement made was disparaging of his rival’s product depended on whether it would be taken ‘seriously’ by a ‘reasonable man’; an alternative test would be whether the trader had in fact highlighted any specific defect in his rival’s goods and (iv) a statement made by a trader puffing his own goods was not actionable.” 

Thereafter Division Bench in the Dabur Colortek case, emphasized the importance of keeping in mind the medium of the advertisement and its story line and further developed the law on comparative advertising: “A plaintiff (such as the Appellant before us) ought not to be hypersensitive as brought out in Dabur India v. Wipro Limited 2006 (32) PTC 677 (Del).”… “Finally, we may mention that Reckitt and Colman of India Ltd. v. M.P. Ramchandran and Anr. 1999 (19) PTC 741 was referred to for the following propositions relating to comparative advertising: (a) A tradesman is entitled to declare his goods to be best in the world, even though the declaration is untrue. (b) He can also say that his goods are better than his competitors', even though such statement is untrue. C S (OS) No. 1588 of 2013 Page 12 of 22 (c) For the purpose of saying that his goods are the best in the world or his goods are better than his competitors' he can even compare the advantages of his goods over the goods of others. (d) He however, cannot, while saying that his goods are better than his competitors', say that his competitors' goods are bad. If he says so, he really slanders the goods of his competitors. In other words, he defames his competitors and their goods, which is not permissible. (e) If there is no defamation to the goods or to the manufacturer of such goods no action lies, but if there is such defamation an action lies and if an action lies for recovery of damages for defamation, then the Court is also competent to grant an order of injunction restraining repetition of such defamation.” 

Applying these principles to the present case, the Court came to a prima facie conclusion that the ads were not disparaging. 

TV and Print ads: According to the court too much could not be read into the ads and to expressions of each individual character. Also, the court noticed that the teeth of the Colgate Boy had not been zoomed into and no gaps or cavities could be seen. The expressions and effects used in the ad, only showed that Pepsodent was a better product but did not disparage Colgate’s product. In this regard, the court observed “If there is a comparison of products and an attempt to show that one is better than the other, then obviously both boys cannot have happy faces.”Also, the court held that the word ‘attack’ in the print ad was related to Pepsodent’s germ fighting capability and was not an attack on Colgate. 

The court denied going into the questions of truthfulness of the ‘130% germ attack’ capability of Pepsodent GSP and the allegation of HUL being in the habit of making misleading claims, at the stage of interim injunction.
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in Comparative Advertising, Trademark | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • IPAB on Payyannur Ring
    [*S lightly long post] Background: The Intellectual Property Appellate Board (“ IPAB ”), in its recent order in SubhashJewellery v. Payyan...
  • Guest Post: Intermediary liability in defamation cases - Parle, Mouthshut & Visakha cases to clarify the law
    Chaitanya Ramachandran, who has blogged for us previously over here and here , has sent us this excellent guest post analyzing the extent of...
  • IP Research Assistant position at IIT, Madras
    Feroz Ali Khader, MHRD IP Chair at the Indian Institute of Technology (IIT) Madras, is looking for research assistants to work on various is...
  • Dorling Kindersley v. Sanguine Technical Publishers
    A recent Delhi High Court order passed on 21 January, 2013  with respect to copyright licensing has come to our notice. An analysis of the j...
  • Call for Papers: IIT Bombay and MHRD jointly announce the 2nd International Conference on Management of Intellectual Property and Strategy
    The readers may be interested to know that the Shailesh J. Mehta School of Management of IIT Bombay is geared up to host, in collaboration w...
  • SpicyIP Tidbit: ALCS August Distribution
    In the UK, the Authors' Licensing and Collecting Society is an organization run and owned by writers that collects money due to its mem...
  • Delhi HC rejects the "Hot News" Doctrine: A Summary
    The applicability of the Hot News doctrine was rejected recently in a landmark ruling delivered by Justice Bhat of the Delhi HC. This post i...
  • Satyajit Ray's sketches and copyright controversies
    A copyright row appears to have started between the Satyajit Ray Society and the Delhi Art Gallery, that is organising a countrywide exhibit...
  • Thalappakatti biryani trademark row
    The southern district of Dindigal in Tamil Nadu occupies a special place in the hearts of biryani lovers. In the late 1950s, one Nagasamy N...
  • Karnataka High Court temporarily restrains German company from exploiting trade secrets of Homag India
    Image from here In an interesting judgment dated 10th October, 2012 the Karnataka High Court, sitting at Bangalore, has passed an interim in...

Categories

  • 126 (1)
  • 3(d) (4)
  • 3(f) (1)
  • 3(i) (1)
  • 3(k) (2)
  • Academic Writing (1)
  • access (10)
  • access to food (1)
  • access to health (3)
  • AIA (1)
  • AIDS/HIV (3)
  • Antitrust (2)
  • Bajaj v LML (1)
  • Basmati Row (2)
  • Biological Diversity (5)
  • Biologics (2)
  • biopiracy (4)
  • biotech (7)
  • Bollywood (25)
  • Broadcasters Rights (5)
  • Budget (1)
  • business method patent (2)
  • Call for papers (2)
  • Cipla (2)
  • Comparative Advertising (4)
  • Competition law (8)
  • Compulsory Licensing (27)
  • condonation of delay (1)
  • Conference (4)
  • Constitution (12)
  • Contracts (1)
  • Controller's decisions (8)
  • Copyright (112)
  • Copyright Amendment Bill 2010 (23)
  • copyright board (4)
  • Copyright Exceptions (6)
  • copyright office (1)
  • Copyright Rules (2013) (5)
  • Copyright Societies (9)
  • Counterfeiting (1)
  • creativity (1)
  • Cross Retaliation (1)
  • csir (4)
  • d (1)
  • D.U. Photocopy Case (16)
  • Darjeeling Tea (3)
  • Data Exclusivity (2)
  • Database (1)
  • DCGI (2)
  • decompilation (2)
  • defamation (9)
  • Designs (3)
  • Designs Act (3)
  • Differential Pricing (2)
  • Dilution (1)
  • Disabilities (3)
  • Disability (2)
  • DMCA (2)
  • Doha Declaration (1)
  • Domain Names (2)
  • Draft Policy of the Indian Government (2)
  • DRM (1)
  • Drug Regulation (7)
  • education (12)
  • Enercon (1)
  • Enforcement (1)
  • EU (2)
  • ex parte (2)
  • exhaustion (3)
  • Exhaustion of Rights (2)
  • Fair Dealing (8)
  • Fair Use (11)
  • Federal Circuit (1)
  • Fees (3)
  • FICCI (7)
  • FRAND (2)
  • free trade agreement (3)
  • FTA (3)
  • G.I. Registry (4)
  • gene sequences (3)
  • Generic medicine (4)
  • Geographical Indication (14)
  • Gilead (1)
  • Glenmark (5)
  • Gopika (34)
  • Guest post (11)
  • guidelines (1)
  • GWU-CII (1)
  • Herceptin (1)
  • hot news (3)
  • ICANN (1)
  • incremental innovation (1)
  • independence (1)
  • india (5)
  • Indian Government (1)
  • Indian patent litigation (27)
  • Indian Pharma (35)
  • Injunction (10)
  • Innovation (7)
  • INTA (1)
  • Intermediaries (10)
  • internet (11)
  • Internet Access Providers (IAPs) (5)
  • Internet Censorship (7)
  • IP scholarship (3)
  • IP aware (4)
  • IP Course (3)
  • IP Education (1)
  • IP Policy (11)
  • IP update (4)
  • ip writing competition (1)
  • IPAB (34)
  • ipchair (1)
  • IPO (1)
  • IPRS (5)
  • IT Act (1)
  • Journal (2)
  • judicial independence (3)
  • Jurisdiction (1)
  • Kruttika (4)
  • Legal Education (3)
  • Legal Research Tools (1)
  • Legal Scholarship (2)
  • library (2)
  • Licensing (7)
  • Madhulika (20)
  • mathematical methods (1)
  • Media law (3)
  • medical method (1)
  • Merck (4)
  • mhrd ip chair (1)
  • Microsoft (3)
  • Middle Path (1)
  • Moral Rights (2)
  • Movies (18)
  • musical work (2)
  • nanotechnology (1)
  • Natco (3)
  • natco defamation suit (5)
  • natco vs bayer (4)
  • need for transparency (1)
  • Novartis (8)
  • Novartis patent case in India (11)
  • NPEs (2)
  • nujs (1)
  • NUJS Conference (2)
  • Obituary (1)
  • obviousness (7)
  • Off-Topic (2)
  • online course (4)
  • Open Access (6)
  • Open Source (2)
  • Opposition (3)
  • Parallel Imports (4)
  • Parliament (1)
  • passing off (5)
  • Patent (52)
  • Patent act (10)
  • patent agent (5)
  • patent agent exam (9)
  • patent agent exam qualifications (3)
  • patent infringement (5)
  • Patent Licensing (2)
  • Patent litigation (2)
  • Patent Office (19)
  • patent pool (3)
  • Patent Prosecution (7)
  • Patent rules (2)
  • Patent Strategies (8)
  • Patents (9)
  • pegasus (1)
  • Personality Rights (1)
  • Pfizer (1)
  • Pharma (18)
  • Piracy (5)
  • plagiarism (3)
  • Plant Variety Protection (2)
  • post grant (1)
  • Prashant (2)
  • Preventive Detention (1)
  • Price Control (6)
  • prior publication (1)
  • Privacy (3)
  • Prizes (1)
  • public health (3)
  • Public Interest (4)
  • Publicity Rights (4)
  • Publishing (3)
  • radio (2)
  • Rajiv (18)
  • Rectification Petition (2)
  • Rejection (1)
  • research (3)
  • reverse engineering (2)
  • revocation (4)
  • rip (1)
  • Roche (2)
  • Roche vs Cipla (1)
  • Royalty (2)
  • RTI (2)
  • Scholarship (4)
  • section 16 (1)
  • Section 3(d) (7)
  • section 8 (6)
  • shamnad (11)
  • Shan Kohli (4)
  • Shouvik Kumar Guha (30)
  • Smartphones/Tablets (2)
  • Social Innovation (1)
  • Software (10)
  • software enforcement (3)
  • software patent (3)
  • Special 301 Report (1)
  • Spicy Tidbits (6)
  • spicyip (1)
  • SpicyIP Accolades (1)
  • SpicyIP Announcements (9)
  • SpicyIP Case (1)
  • SpicyIP Cases (3)
  • spicyip commiseration (1)
  • SpicyIP Events (11)
  • SpicyIP Fellowship (5)
  • SpicyIP Guest Series (22)
  • SpicyIP Interview (2)
  • SpicyIP Jobs (4)
  • SpicyIP Jobs/General (2)
  • SpicyIP Review (1)
  • SpicyIP Tidbits (11)
  • SpicyIP Weekly Review (27)
  • Statutory Licensing (1)
  • STI Policy 2013 (4)
  • Sugen (3)
  • Supreme Court of India (5)
  • Swaraj (19)
  • Tarnishment (1)
  • Technology (6)
  • Technology Transfer (5)
  • TKDL (5)
  • TPP (1)
  • trade (4)
  • Trade Secret Protection (1)
  • Trademark (59)
  • Trademark dilution (1)
  • Trademark Registry (9)
  • Traditional Knowledge (7)
  • Transparency (5)
  • treaty (1)
  • trial (1)
  • tribunals (2)
  • TRIPS (11)
  • UK (3)
  • unfair competition (5)
  • UNFCCC (1)
  • Universities Research and Innovation Bill (2)
  • US (1)
  • US Patent Reform (1)
  • US Supreme Court (3)
  • viva (3)
  • WIPO (5)
  • Working a Patent (2)
  • Workshop (4)
  • writ (1)
  • WTO (1)

Blog Archive

  • ▼  2013 (364)
    • ►  September (13)
    • ▼  August (41)
      • SpicyIP Tidbit: ALCS August Distribution
      • PIP Essay Competition Results Announced: Meet the ...
      • Now Showing: Satyagraha: Bom HC denies an Injuncti...
      • Patenting food: Plumpy’ Nut and more?
      • Bollywood flick Satyagraha faces dispute over its ...
      • Leading IP Academics Fired: Protest Petition Again...
      • Two MHRD IP Chair Professors axed; Reasons unknown
      • FICCI and The George Washington University, Washin...
      • SpicyIP Tidbit: IPA continues communication with P...
      • SpicyIP Tidbit: GI for Pedana Kalamkari Art Form
      • Colgate v Pepsodent: Comparative Advertising
      • SpicyIP Tidbit: Justice KN Basha to be new IPAB ch...
      • IPRS complies with new copyright law & decides to ...
      • Re-imposing curbs on royalty payments to foreigners
      • Debating the CIS Draft Bill on Privacy: Should thi...
      • The BDR compulsory licensing application and the B...
      • Satyajit Ray's sketches and copyright controversies
      • Rihanna's victory in the Topshop T-shirt case
      • When cancer drugs stop being “necessities”: A case...
      • SpicyIP Tidbit: Singers from the South in support ...
      • Loss of an IP Leader: RIP Prof Daruwalla
      • Part II: IPAB revokes Allergan's patent on eye dru...
      • Part I: IPAB revokes Allergan's patent on eye drug...
      • Feedback on draft guidelines for Computer Related ...
      • A naïve report from Parliament on FDI in the Pharm...
      • INTAvening in the Supreme Court: Parallel Imports ...
      • Surprising news! - Roche decides to not ‘pursue’ H...
      • Independent Intellectual Property: Gunning For (or...
      • SpicyIP Tidbit: Special Services announced by WIP...
      • GI News: Kaipad Rice, Nagpur Oranges, Dharmavaram ...
      • SpicyIP Tidbit: Patent Office confirms status of G...
      • The Sholay litigation saga
      • SpicyIP Tidbit: Has Genentech’s main Herceptin pat...
      • Bollywood flick 'I love NY' accused of plagiarisin...
      • The Herceptin patent fiasco at the Indian Patent O...
      • IPO vs IPAB: IT Prowess and Transparency?
      • Ghost Post: Samsung v. Apple Presidential Enforcem...
      • Delhi HC dismisses Rediff.com's Copyright Infringe...
      • UNICEF Supply Annual Report 2012 : India is the La...
      • Raj Anand Moot Court Competition 2013
      • Breaking News: GSK patents challenged: IPAB revoke...
    • ►  July (36)
    • ►  June (36)
    • ►  May (32)
    • ►  April (51)
    • ►  March (66)
    • ►  February (40)
    • ►  January (49)
  • ►  2012 (131)
    • ►  December (29)
    • ►  November (42)
    • ►  October (50)
    • ►  September (10)
Powered by Blogger.